DocCheck AG (FRA:AJ91) GF Value Rank: 6 (As of Aug. 22, 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:AJ91 DocCheck AG FRA:AJ91
71 GF Score
Price €10.80
GF Value €9.41
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is DocCheck AG GF Value Rank?

DocCheck AG FRA:AJ91 +0.93% 71 GF Value Rank is 6 as of Aug. 22, 2026, which is at its 10-year median of 6.00. GuruFocus rates FRA:AJ91 with a GF Score™ of 71/100 and a GF Value™ of €9.41 (Modestly Overvalued). The stock has 3 warning signs investors should review.

DocCheck AG has the GF Value Rank of 6.

GF Value Rank evaluates the exclusive GuruFocus valuation and performance of a stock, rated on a scale from 1 to 10. It is determined by the price-to-GF-Value (P/GF Value) ratio, a proprietary metric calculated based on historical multiples along with an adjustment factor based on a company's past returns and growth and future estimates of the business' performance.

GuruFocus found that for valuation, we cannot simply give stocks a better GF Value rank simply because they have a lower P/GF Value ratio. Backtesting shows that over the long term, the two worst-performing groups are the most expensive group (with the highest P/GF Value ratio) and the least expensive group (with the lowest P/GF Value ratio).

We can understand why the most expensive group underperforms. We were initially puzzled by the underperformance of the least expensive group, but we realized there is a reason why some stocks are super cheap. If they look too undervalued, it is often because the businesses behind them are poor quality. The market realized this and gave them low valuations. In a way, the market is efficient.

After multiple backtesting analyses, we granted the stocks in third-cheapest percentile the highest GF Value rank, as they have performed the best over a full market cycle. Stock performance is actually not as sensitive to valuation as it is to growth and profitability. On average, the companies in the 20%-50% valuation groups have similar performances. Therefore, we should avoid the most expensive and the least expensive stocks. We can be more tolerant of valuation.

A higher score indicates a stock with a relatively low valuation and substantial potential for outperformance. Conversely, a lower score often reflects stocks that are either highly overvalued or deeply undervalued, both of which tend to underperform.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.


DocCheck AG GF Value Rank Related Terms


FRA:AJ91 vs VEEV, BTSG, HQY: GF Value Rank Comparison

For the Health Information Services subindustry, DocCheck AG's GF Value Rank, along with its competitors' market caps and GF Value Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DocCheck AG GF Value Rank vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, DocCheck AG's GF Value Rank distribution charts can be found below:

* The bar in red indicates where DocCheck AG's GF Value Rank falls into.


FRA:AJ91
71GF Score
DocCheck AG FRA:AJ91
GF Value Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Value Rank →
What does a GF Value Rank of 6 mean?
DocCheck AG (FRA:AJ91) has a GF Value Rank of 6 as of Aug. 22, 2026. GF Value Rank is given based on historical multiples along with past returns, growth and future estimates of the business' performance. View historical data on DocCheck AG and its competitors. This is near median its historical median of 6.00. Over the past decade, DocCheck AG's GF Value Rank has ranged from 1.00 to 10.00.
Is DocCheck AG's GF Value Rank too high?
DocCheck AG's current GF Value Rank of 6 is near median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 10.00. Overall, DocCheck AG has a GF Score™ of 71/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does DocCheck AG's GF Value Rank compare to VEEV and BTSG?
DocCheck AG's GF Value Rank of 6 can be compared against companies in the Healthcare Providers & Services industry. Historically, DocCheck AG's own GF Value Rank has ranged from 1.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Value Rank for a Healthcare Providers & Services company?
A good GF Value Rank depends on the Healthcare Providers & Services industry context. However, GF Value Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Value Rank mean?
A high GF Value Rank can signal that a stock is expensive relative to its fundamentals. GF Value Rank is given based on historical multiples along with past returns, growth and future estimates of the business' performance. View historical data on DocCheck AG and its competitors. DocCheck AG's current GF Value Rank is 6, which is near median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DocCheck AG stock overvalued right now?
Based on GuruFocus' analysis, DocCheck AG (FRA:AJ91) is currently considered Modestly Overvalued. The stock's GF Value™ is €9.41, compared to a current price of €10.80 — trading 14.8% above its estimated fair value. The current GF Value Rank is 6, which is near median its 10-year median of 6.00. DocCheck AG's overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Value Rank calculated?
GF Value Rank is calculated from a company's financial statements. For DocCheck AG (FRA:AJ91), the current GF Value Rank is 6 as of Aug. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DocCheck AG (FRA:AJ91) Overvalued in 2026?

Based on GuruFocus' analysis, DocCheck AG stock appears to be overvalued. The current stock price of €10.80 is trading 14.8% above its estimated GF Value™ of €9.41. GuruFocus considers DocCheck AG to be Modestly Overvalued.

Key valuation signals for FRA:AJ91:

  • GF Value Rank: 6 (near median its 10-year median of 6.00)
  • GF Value™: €9.41 vs. price of €10.80 (14.8% above fair value)
  • GF Score™: 71/100 with 3 warning signs

No single metric tells the full story. See the FRA:AJ91 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


DocCheck AG Business Description

Other Exchanges AJ91:Germany
Address Doccheck AG, Vogelsanger Strac E 66, Koln, DEU, 50823
DocCheck AG is a Germany-based company engaged in the healthcare sector. It operates through subsidiaries: antwerpes AG develops integrated communication concepts for the healthcare sector, including social media and digital communication with focus on e-marketing concepts, search engine optimization (SEO), search engine advertising (SEA) and search engine marketing (SEM); DocCheck Medical Services GmbH operates an online platform for healthcare professionals, such as physicians and pharmacists; DocCheck Medizinbedarf und Logistik GmbH wholesales medical products from third parties and also produces own medical products, and DocCheck Guano AG is a venture capital company with focus on e-health companies and promotes healthcare startups.
71GF Score

Get the complete analysis for FRA:AJ91

GF Value Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€10.80
Price
€9.41
GF Value